About: Predicting potential drug targets and repurposable drugs for COVID-19 via a deep generative model for graphs

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Predicting potential drug targets and repurposable drugs for COVID-19 via a deep generative model for graphs Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Predicting potential drug targets and repurposable drugs for COVID-19 via a deep generative model for graphs
Creator	Bandyopadhyay, Sanghamitra Lall, Snehalika Mukhopadhyay, Anirban Ray, Sumanta Schönhuth, Alexander
Source	ArXiv
abstract	Coronavirus Disease 2019 (COVID-19) has been creating a worldwide pandemic situation. Repurposing drugs, already shown to be free of harmful side effects, for the treatment of COVID-19 patients is an important option in launching novel therapeutic strategies. Therefore, reliable molecule interaction data are a crucial basis, where drug-/protein-protein interaction networks establish invaluable, year-long carefully curated data resources. However, these resources have not yet been systematically exploited using high-performance artificial intelligence approaches. Here, we combine three networks, two of which are year-long curated, and one of which, on SARS-CoV-2-human host-virus protein interactions, was published only most recently (30th of April 2020), raising a novel network that puts drugs, human and virus proteins into mutual context. We apply Variational Graph AutoEncoders (VGAEs), representing most advanced deep learning based methodology for the analysis of data that are subject to network constraints. Reliable simulations confirm that we operate at utmost accuracy in terms of predicting missing links. We then predict hitherto unknown links between drugs and human proteins against which virus proteins preferably bind. The corresponding therapeutic agents present splendid starting points for exploring novel host-directed therapy (HDT) options.
has issue date	2020-07-05(xsd:dateTime)
has license	arxiv
sha1sum (hex)	d22d8ca8776611e41620a5facf8dbf5ee0abe9d0
resource representing a document's title	Predicting potential drug targets and repurposable drugs for COVID-19 via a deep generative model for graphs
resource representing a document's body	covid:d22d8ca8776611e41620a5facf8dbf5ee0abe9d0#body_text
is schema:about of	named entity 'manipulate' named entity 'April' named entity 'Here' named entity 'molecule' named entity 'therapeutic' named entity 'reliable' named entity 'artificial intelligence' named entity 'confirm' named entity 'COVID-19' named entity 'OPTION' named entity 'MACHINERY' named entity 'HUMAN CELLS' named entity 'TARGET' named entity 'virus' named entity 'bind' named entity 'therapies' named entity 'predict' named entity '2019' named entity 'virus' named entity 'simulations' named entity 'For' named entity 'side effects' named entity 'deep' named entity 'Predicting' named entity 'virus to enter' named entity 'virus' named entity 'protein-protein interaction' named entity 'deep learning' named entity 'host-directed' named entity 'COVID' named entity 'therapeutic agents' named entity 'virus' named entity 'arXiv' named entity 'drug targets' named entity 'CD4' named entity 'host cell' named entity 'protein interaction' named entity 'proinflammatory cytokines' named entity 'latent variables' named entity 'enzyme' named entity 'virus' named entity 'adjacency matrix' named entity 'SARS-CoV-2' named entity 'probability' named entity 'SARS' named entity 'objective function' named entity 'Cardiac glycosides' named entity 'clustering algorithm' named entity 'probability' named entity 'respiratory tract infections' named entity 'virus' named entity 'protein interaction' named entity 'Baclofen' named entity 'Chlortetracycline' named entity 'neural network' named entity 'COVID' named entity 'virus' named entity 'nucleocapsid' named entity 'nucleocapsid' named entity 'Pneumocystis pneumonia' named entity 'Captopril' named entity 'molecular mechanism' named entity 'mass spectrometry' named entity 'virulence' named entity 'HIV-1' named entity 'MERS-CoV' named entity 'memory cell' named entity 'drug targets' named entity 'camptothecin' named entity 'SARS-CoV-2' named entity 'asthma' named entity 'ChEMBL' named entity 'binding site' named entity 'convolution' named entity 'virus infection' named entity 'Coronavirus Disease' named entity 'life cycle' named entity 'Resveratrol' named entity '3CL protease' named entity 'protein interaction' named entity 'broad spectrum' named entity 'DNA synthesis' named entity 'SARS-CoV-2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software